Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared a post on X:
“Could proton therapy become the new standard of care for stage III NSCLC treated with radiation therapy?
In 2013, the NCI invested in a study that just might prove that to be the case, supporting the enrollment of 330 participants in the RTOG 1308 study.”
Other articles featuring Drew Moghanaki on OncoDaily.